Zhejiang Medicine shareholder plans up to 1% stake sale

Zhejiang Medicine (SSE:600216) announced that shareholder National High-Tech Investment Co., Ltd. plans to reduce its holdings by no more than 9,616,377 shares, representing up to 1% of the company's total share capital. The sale will occur via a block trade within three months after 15 trading days from the announcement date, specifically between April 11, 2025, and July 10, 2025, depending on prevailing market conditions. As of the announcement, National High-Tech Investment holds 150,127,573 shares, equivalent to 15.61% of Zhejiang Medicine. The planned reduction is driven by the shareholder's business development needs, using shares obtained both before the company's IPO and through other means.